288-16-4, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 288-16-4, name is Isothiazole, introducing its new discovery.
Amino pyridine derivatives
Novel 4-pyridinamine derivatives having the formula STR1 [where R1 and R2 are aryl or heteroaryl (optionally linked together by a lower alkylene bridge) or one of R1 and R2 is aryl or heteroaryl and the other of R1 and R2 is lower alkyl or ar(lower)alkyl, R3 and R4 are each hydrogen or lower alkyl and n is 0 or 1] and their non-toxic acid addition salts are described. They show CNS activity and may be used as antidepressant drugs. Some also show stimulant activity. Novel intermediates having the formula STR2 are also described.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.288-16-4, you can also check out more blogs about288-16-4
Reference£º
Isothiazole – Wikipedia,
Isothiazole – ScienceDirect.com